Vaccines and Prevention

  • Robert A. Norman
  • Sharad P. Paul


I was in my first week as a newly graduated doctor when I encountered a vaccine-skeptic – a patient who was convinced vaccines were dangerous and could weaken the human race. I remember thinking – as a doctor, I am supposed to take a detailed history, but I hope you forgive me if I switch off just for a little bit, because right now isn’t the time for this debate. You learn something at medical school and immediately try to tell people about it, but you can’t convince them – not easily, anyway. Especially if you have been indoctrinated with factual information along the lines of this: an estimated 1.5 million children die each year—one every 20 s—from vaccine-preventable diseases such as diarrhea and pneumonia.


Measle Vaccine AIDS Epidemic Vaccine Shortage Amyl Nitrate Salk Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Offit PA. The cutter incident, 50 years later. N Engl J Med. 2005;352:1411–1412. DOI  10.1056/NEJMp048180
  2. 2.
    Reidl S. Edward Jenner and the history of smallpox and vaccination. Baylor Univ Med Centre Proc. 2005;18:21–25.Google Scholar
  3. 3.
    Mullin D. Prometheus in Gloucestershire: Edward Jenner, 1749–1823. J Aller Clin Immunol. 2003;112:810–4.CrossRefGoogle Scholar
  4. 4.
    Marshall GS. The vaccine handbook: a practical guide for clinicians: the purple book. New York: Professional Communications, PCI Books; 2010.Google Scholar
  5. 5.
    Parry E. Principles of medicine in Africa. Cambridge: Cambridge University Press; 2004.Google Scholar
  6. 6.
    Alba-Lois L, Segal-Kischinevzky C. Beer & wine makers. Nat Educ. 2010;3(9):17.Google Scholar
  7. 7.
    The Vaccine Knowledge project. University of Oxford. Accessed 25 Dec 2015.
  8. 8.
    Flam F. Vaccines that alter evolution. Forbes. Pharma and Healthcare section, July 28, 2015.Google Scholar
  9. 9.
    The AIDS Epidemic. 7 ed. Burlington, Massachusetts, United States: Jones & Bartlett Learning; 2013.Google Scholar
  10. 10.
    Chan J. Scaling up the Ebola response: what we learned from AIDS activism. J AIDS HIV Infect. 2015;1(1):1–5.Google Scholar
  11. 11.
    Regules JA and Others. A recombinant vesicular stomatitis virus Ebola vaccine — preliminary report. N Engl J Med. 2017 Jan 26;376(4):330–341. doi:  10.1056/NEJMoa1414216. epub Apr 1, 2015.
  12. 12.
    Henao-Restrepo AM and Others. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Robert A. Norman
    • 1
  • Sharad P. Paul
    • 2
    • 3
  1. 1.Department of DermatologyNova Southeastern Medical SchoolFt. LauderdaleUSA
  2. 2.Faculty of Surgery, School of MedicineUniversity of QueenslandBrisbaneAustralia
  3. 3.AUTAucklandNew Zealand

Personalised recommendations